Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization

Cancer neoantigens that arise from somatic mutations have emerged as important targets for personalized immunization. Here, we report an improved overall survival of a HER2-positive metastatic breast cancer patient using a bioinformatic-based personalized peptide immunization called BITAP (BioInform...

Descripción completa

Detalles Bibliográficos
Autores principales: Schönharting, Wolfgang, Roehnisch, Tim, Manoochehri, Mehdi, Christoph, Jan, Sieger, Marie, Nogueira, Mauro, Martos-Contreras, Mari Carmen, Kunz, Meik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301538/
https://www.ncbi.nlm.nih.gov/pubmed/37376412
http://dx.doi.org/10.3390/vaccines11061023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301538/
https://www.ncbi.nlm.nih.gov/pubmed/37376412
http://dx.doi.org/10.3390/vaccines11061023

Ejemplares similares